{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:57:37Z","timestamp":1790009857417,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.canep.2010.07.001","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T06:43:04Z","timestamp":1280817784000},"page":"112-119","source":"Crossref","is-referenced-by-count":16,"title":["Characteristics and survival associated with ovarian cancer diagnosed as first cancer and ovarian cancer diagnosed subsequent to a previous cancer"],"prefix":"10.1016","volume":"35","author":[{"given":"Zahava","family":"Berkowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hee","family":"Rim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"Peipins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canep.2010.07.001_bib1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/01.AOG.0000260392.70365.5e","article-title":"Symptoms, diagnoses, and time to key diagnostic procedures among older U.S. women with ovarian cancer","volume":"109","author":"Ryerson","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.canep.2010.07.001_bib2","unstructured":"U.S. Cancer Statistics Working Group. United States cancer statistics: 1999\u20132005 incidence and mortality web-based report. Atlanta, GA: Department of Health and Human Services, Center for Disease Control and Prevention; Washington, DC: National Cancer Institute; 2009. Available at: www.cdc.gov\/uscs."},{"issue":"1","key":"10.1016\/j.canep.2010.07.001_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"3 Pt 1","key":"10.1016\/j.canep.2010.07.001_bib4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.AOG.0000231680.58221.a7","article-title":"Patterns and progress in ovarian cancer over 14 years","volume":"108","author":"Chan","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.canep.2010.07.001_bib5","series-title":"Cancer epidemiology and prevention","first-page":"1013","article-title":"Ovarian cancer","author":"Hankinson","year":"2007"},{"issue":"8","key":"10.1016\/j.canep.2010.07.001_bib6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1047-2797(01)00213-7","article-title":"Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness","volume":"11","author":"Modugno","year":"2001","journal-title":"Ann Epidemiol"},{"issue":"2","key":"10.1016\/j.canep.2010.07.001_bib7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2004.10.037","article-title":"Histologic types of epithelial ovarian cancer: have they different risk factors?","volume":"96","author":"Kurian","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.canep.2010.07.001_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwg177","article-title":"Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study","volume":"158","author":"Tung","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.canep.2010.07.001_bib9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cncr.20138","article-title":"Familial association of specific histologic types of ovarian malignancy with other malignancies","volume":"100","author":"Bermejo","year":"2004","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.canep.2010.07.001_bib10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.bjc.6604241","article-title":"Second malignancies after breast cancer: the impact of different treatment modalities","volume":"98","author":"Kirova","year":"2008","journal-title":"Br J Cancer"},{"issue":"15","key":"10.1016\/j.canep.2010.07.001_bib11","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.ejca.2005.01.029","article-title":"Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972\u20132001","volume":"41","author":"Soerjomataram","year":"2005","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.canep.2010.07.001_bib12","first-page":"995","article-title":"Second primary ovarian cancer among women diagnosed previously with cancer","volume":"10","author":"Hall","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.canep.2010.07.001_bib13","series-title":"Surveillance epidemiology and end result (SEER)","author":"National Cancer Institute Surveillance Research Program","year":"2007"},{"key":"10.1016\/j.canep.2010.07.001_bib14","unstructured":"The SEER program code manual. Report No.: 3rd ed. Bethesda, MD: National Cancer Institute; 1998."},{"key":"10.1016\/j.canep.2010.07.001_bib15","series-title":"New malignancies among cancer survivors: SEER cancer registries, 1973\u20132000. Ref type: serial (book, monograph)","article-title":"Methods","author":"Curtis","year":"2006"},{"key":"10.1016\/j.canep.2010.07.001_bib16","series-title":"SEER summary staging manual-2000: codes and coding instructions. NIH Pub. No. 01-4969","author":"Young","year":"2001"},{"key":"10.1016\/j.canep.2010.07.001_bib17","series-title":"Survival analysis using the SAS system. A practical guide","author":"Allison","year":"1995"},{"key":"10.1016\/j.canep.2010.07.001_bib18","series-title":"Modeling survival data in medical research","author":"Collet","year":"1994"},{"key":"10.1016\/j.canep.2010.07.001_bib19","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1200\/JCO.2003.08.065","article-title":"Patterns of chemotherapy use for women with ovarian cancer: a population-based study","volume":"21","author":"Cress","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canep.2010.07.001_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/02841860701784544","article-title":"Survival in ovarian cancer patients by histology and family history","volume":"47","author":"Ji","year":"2008","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.canep.2010.07.001_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ygyno.2008.01.033","article-title":"Conditional survival in ovarian cancer: results from the SEER dataset 1988\u20132001","volume":"109","author":"Choi","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.canep.2010.07.001_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/gyno.2000.5805","article-title":"Long-term results and prognostic factors in patients with epithelial ovarian cancer","volume":"78","author":"Brun","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.canep.2010.07.001_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1525-1438.2003.13381.x","article-title":"Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer","volume":"13","author":"Ikeda","year":"2003","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.canep.2010.07.001_bib24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jnci\/djj019","article-title":"Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients","volume":"98","author":"Earle","year":"2006","journal-title":"JNCI"},{"key":"10.1016\/j.canep.2010.07.001_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","article-title":"Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer","volume":"72","author":"Bristow","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.canep.2010.07.001_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.canep.2010.07.001_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-4608(91)90093-A","article-title":"Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II): genetics, pathology, natural history, and cancer control, part I","volume":"53","author":"Lynch","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"10.1016\/j.canep.2010.07.001_bib28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ygyno.2005.10.029","article-title":"The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer","volume":"101","author":"Malander","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canep.2010.07.001_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.epirev.a017948","article-title":"Genetic epidemiology of breast and ovarian cancers","volume":"19","author":"Newman","year":"1997","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.canep.2010.07.001_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9378(98)70476-4","article-title":"BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing","volume":"178","author":"Rubin","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.canep.2010.07.001_bib31","series-title":"Cancer epidemiology and prevention","first-page":"1269","article-title":"Multiple primary cancers","author":"Schottenfeld","year":"2006"},{"key":"10.1016\/j.canep.2010.07.001_bib32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/hmg\/10.7.705","article-title":"BRCA1 and BRCA2 and the genetics of breast and ovarian cancer","volume":"10","author":"Welcsh","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.canep.2010.07.001_bib33","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/aje\/152.12.1154","article-title":"Familial breast and ovarian cancer: a Swedish population-based register study","volume":"152","author":"Anderson","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.canep.2010.07.001_bib34","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/1097-0142(19910801)68:3<660::AID-CNCR2820680337>3.0.CO;2-5","article-title":"Are malignant melanoma patients at higher risk for a second cancer?","volume":"68","author":"Gutman","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2010.07.001_bib35","first-page":"195","article-title":"Clinical characteristics of patients with a second primary tumor in the endometrium or ovary","volume":"16","author":"Robinson","year":"1995","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.canep.2010.07.001_bib36","series-title":"Clinical gynecologic oncology","article-title":"Endometrial cancer","author":"Cook","year":"2007"},{"key":"10.1016\/j.canep.2010.07.001_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.canep.2010.07.001_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cdp.2004.11.002","article-title":"Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk","volume":"29","author":"Mills","year":"2005","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.canep.2010.07.001_bib39","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2265.1998.00577.x","article-title":"Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence","volume":"49","author":"Riman","year":"1998","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.canep.2010.07.001_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"3 Pt 1","key":"10.1016\/j.canep.2010.07.001_bib41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ajog.2005.01.091","article-title":"Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs","volume":"193","author":"Althuis","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"19","key":"10.1016\/j.canep.2010.07.001_bib42","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/jnci\/djj375","article-title":"Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort","volume":"98","author":"Lacey","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canep.2010.07.001_bib43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jama.2009.1052","article-title":"Hormone therapy and ovarian cancer","volume":"302","author":"Morch","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2010.07.001_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2307\/3577477","article-title":"Radiation dose and second cancer risk in patients treated for cancer of the cervix","volume":"116","author":"Boice","year":"1988","journal-title":"Radiat Res"},{"key":"10.1016\/j.canep.2010.07.001_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1023002322935","article-title":"Building the infrastructure for nationwide cancer surveillance and control\u2014a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States)","volume":"14","author":"Wingo","year":"2003","journal-title":"Cancer Causes Control"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782110001268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782110001268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T21:52:35Z","timestamp":1544305955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782110001268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1877782110001268"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2010.07.001","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}